New study investigates whether chemoradiation before surgery reduces cancer cells in the blood

NCT ID NCT07194616

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This clinical trial is looking at how chemoradiation given before surgery affects circulating tumor cells (CTCs) in patients with stage II-III rectal cancer. CTCs are cancer cells that travel in the blood and may indicate how likely the cancer is to spread. The study will compare two groups: one that gets chemoradiation followed by surgery, and another that has surgery alone. By tracking CTCs over time, researchers hope to learn more about which treatment approach might be better at controlling the disease.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
fluoropyrimidine-based chemotherapy and radiotherapy
What this could lead to
If successful, this study could help doctors understand whether chemoradiation before surgery reduces the spread of cancer cells in the bloodstream, potentially guiding better treatment decisions for rectal cancer.
What could go wrong
This is an early-stage observational trial focused on a biomarker, not a direct treatment outcome. The results may not lead to immediate changes in patient care, and the sample size is relatively small.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL CANCER PATIENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Municipal Hospital Ostrava - Fifejdy

    RECRUITING

    Ostrava, 728 80, Czechia

  • Palacky University Olomouc, Faculty of Medicine

    RECRUITING

    Olomouc, Czechia

  • University Hospital Olomouc

    RECRUITING

    Olomouc, 779 00, Czechia

  • University Hospital Ostrava

    RECRUITING

    Ostrava, 70852, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.